Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuronetics (STIM) Free Cash Flow (2017 - 2025)

Neuronetics (STIM) has disclosed Free Cash Flow for 9 consecutive years, with $710000.0 as the latest value for Q4 2025.

  • Quarterly Free Cash Flow rose 109.82% to $710000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$21.2 million through Dec 2025, up 31.72% year-over-year, with the annual reading at -$21.2 million for FY2025, 31.72% up from the prior year.
  • Free Cash Flow for Q4 2025 was $710000.0 at Neuronetics, up from -$1.4 million in the prior quarter.
  • The five-year high for Free Cash Flow was $1.3 million in Q4 2023, with the low at -$17.2 million in Q1 2025.
  • Average Free Cash Flow over 5 years is -$7.3 million, with a median of -$6.9 million recorded in 2024.
  • The sharpest move saw Free Cash Flow skyrocketed 144.35% in 2023, then crashed 659.75% in 2024.
  • Over 5 years, Free Cash Flow stood at -$4.4 million in 2021, then surged by 34.04% to -$2.9 million in 2022, then soared by 144.35% to $1.3 million in 2023, then plummeted by 659.75% to -$7.2 million in 2024, then surged by 109.82% to $710000.0 in 2025.
  • According to Business Quant data, Free Cash Flow over the past three periods came in at $710000.0, -$1.4 million, and -$3.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.